Effect of COVID-19 outbreak on the treatment time of patients with acute ST-segment elevation myocardial infarction

Meng-Yun Zhou,Lan Ye,Zhao Xu,Juan Chen,Ming-Wei Wang,Xin-yan Fu,Xiang-feng Shen,Yong-ran Cheng,Zhan-hui Feng,Xing-wei Zhang
DOI: https://doi.org/10.1016/j.ajem.2020.09.038
IF: 3.6
2021-06-01
The American Journal of Emergency Medicine
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Objective</h3><p>To explore the effect of COVID-19 outbreak on the treatment time of patients with ST-segment elevation myocardial infarction (STEMI) in Hangzhou, China.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>We retrospectively reviewed the data of STEMI patients admitted to the Hangzhou Chest Pain Center (CPC) during a COVID-19 epidemic period in 2020 (24 cases) and the same period in 2019 (29 cases). General characteristics of the patients were recorded, analyzed, and compared. Moreover, we compared the groups for the time from symptom onset to the first medical contact (SO-to-FMC), time from first medical contact to balloon expansion (FMC-to-B), time from hospital door entry to first balloon expansion (D-to-B), and catheter room activation time. The groups were also compared for postoperative cardiac color Doppler ultrasonographic left ventricular ejection fraction (LVEF),the incidence of major adverse cardiovascular and cerebrovascular events (MACCE),Kaplan-Meier survival curves during the 28 days after the operation.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>The times of SO-to-FMC, D-to-B, and catheter room activation in the 2020 group were significantly longer than those in the 2019 group (<em>P</em> &lt; 0.05). The cumulative mortality after the surgery in the 2020 group was significantly higher than the 2019 group (<em>P</em> &lt; 0.05).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>The pre-hospital and in-hospital treatment times of STEMI patients during the COVID-19 epidemic were longer than those before the epidemic. Cumulative mortality was showed in Kaplan-Meier survival curves after the surgery in the 2020 group was significantly different higher than the 2019 group during the 28 days.The diagnosis and treatment process of STEMI patients during an epidemic should be optimized to improve their prognosis.</p>
emergency medicine
What problem does this paper attempt to address?
The problem this paper attempts to address is the impact of the COVID-19 pandemic on the treatment times for patients with acute ST-segment elevation myocardial infarction (STEMI). Specifically, the researchers conducted a retrospective analysis of the clinical data of STEMI patients treated at the Hangzhou Chest Pain Center (CPC) during the pandemic in 2020 and compared it with the same period in 2019. They compared key time metrics between the two groups of patients, including the time from symptom onset to first medical contact (SO-to-FMC), the time from first medical contact to balloon inflation (FMC-to-B), the time from hospital door to balloon inflation (D-to-B), and the catheterization lab activation time. Additionally, they compared the incidence of major adverse cardiovascular and cerebrovascular events (MACCE) and cumulative mortality within 28 days post-operation between the two groups. The study results indicate that the treatment times for STEMI patients were significantly prolonged during the COVID-19 pandemic in 2020, and the cumulative mortality within 28 days post-operation was significantly higher compared to the same period in 2019. This suggests that the COVID-19 pandemic negatively impacted the diagnosis and treatment process for STEMI patients, highlighting the need to optimize diagnostic and treatment procedures during the pandemic to improve patient outcomes.